Reuters logo
BRIEF-GlaxoSmithKline Says Gets Positive CHMP Opinion For Juluca In Europe
March 23, 2018 / 11:39 AM / a month ago

BRIEF-GlaxoSmithKline Says Gets Positive CHMP Opinion For Juluca In Europe

March 23 (Reuters) - GlaxoSmithKline Plc:

* VIIV - CHMP POSITIVE OPINION FOR JULUCA IN EUROPE

* ‍VIIV HEALTHCARE GAINS CHMP POSITIVE OPINION FOR JULUCA (DOLUTEGRAVIR/RILPIVIRINE) IN EUROPE​

* FINAL EC DECISION ON EUROPEAN APPROVAL FOR DOLUTEGRAVIR/RILPIVIRINE IS ANTICIPATED TOWARDS END OF Q2 OF 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below